Antibe Therapeutics Stock Forecast, Price & News

Antibe Therapeutics (OTCMKTS:ATBPF) Frequently Asked Questions

Is Antibe Therapeutics a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Antibe Therapeutics in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Antibe Therapeutics stock.
View analyst ratings for Antibe Therapeutics or view top-rated stocks.

Are investors shorting Antibe Therapeutics?

Antibe Therapeutics saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 102,000 shares, a decline of 42.3% from the October 31st total of 176,800 shares. Based on an average trading volume of 150,100 shares, the days-to-cover ratio is presently 0.7 days.
View Antibe Therapeutics' Short Interest.

When is Antibe Therapeutics' next earnings date?

Antibe Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Antibe Therapeutics.

How were Antibe Therapeutics' earnings last quarter?

Antibe Therapeutics Inc. (OTCMKTS:ATBPF) released its earnings results on Tuesday, November, 16th. The company reported ($0.13) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.11) by $0.02. Antibe Therapeutics had a negative net margin of 244.59% and a negative trailing twelve-month return on equity of 57.68%.
View Antibe Therapeutics' earnings history.

What price target have analysts set for ATBPF?

6 brokerages have issued twelve-month price targets for Antibe Therapeutics' stock. Their forecasts range from $4.00 to $5.00. On average, they anticipate Antibe Therapeutics' stock price to reach $4.50 in the next year. This suggests a possible upside of 720.9% from the stock's current price.
View analysts' price targets for Antibe Therapeutics or view top-rated stocks among Wall Street analysts.

Who are Antibe Therapeutics' key executives?

Antibe Therapeutics' management team includes the following people:

• Daniel Legault, President, Chief Executive Officer & Director
• Alain Wilson, Chief Financial Officer
• John Lawrence Wallace, Director & Chief Scientific Officer
• Joseph W. Stauffer, Chief Medical Officer
• David Vaughan, Chief Development Officer

Who are some of Antibe Therapeutics' key competitors?

Some companies that are related to Antibe Therapeutics include Entasis Therapeutics (ETTX), Otonomy (OTIC), Kala Pharmaceuticals (KALA), IMV (IMV), ContraFect (CFRX), 180 Life Sciences (ATNF), Mereo BioPharma Group (MREO), 4D pharma (LBPS), F-star Therapeutics (FSTX), Trevena (TRVN), Flora Growth (FLGC), scPharmaceuticals (SCPH), Heat Biologics (HTBX), BioLineRx (BLRX) and Qilian International Holding Group (QLI).
View all of ATBPF's competitors.

What is Antibe Therapeutics' stock symbol?

Antibe Therapeutics trades on the OTCMKTS under the ticker symbol "ATBPF."

How do I buy shares of Antibe Therapeutics?

Shares of ATBPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Antibe Therapeutics' stock price today?

One share of ATBPF stock can currently be purchased for approximately $0.55.

How much money does Antibe Therapeutics make?

Antibe Therapeutics has a market capitalization of $28.40 million and generates $7.67 million in revenue each year. The company earns $-19.93 million in net income (profit) each year or ($0.48) on an earnings per share basis.

How many employees does Antibe Therapeutics have?

Antibe Therapeutics employs 47 workers across the globe.

What is Antibe Therapeutics' official website?

The official website for Antibe Therapeutics is www.antibethera.com.

Where are Antibe Therapeutics' headquarters?

Antibe Therapeutics is headquartered at 15 PRINCE ARTHUR AVENUE, TORONTO A6, M5R 1B2.

How can I contact Antibe Therapeutics?

Antibe Therapeutics' mailing address is 15 PRINCE ARTHUR AVENUE, TORONTO A6, M5R 1B2. The company can be reached via phone at (416) 922-3460 or via email at [email protected].